Document resource
This article1 has been corrected after publication. The competing interests statement has been amended to note that author Robert Howard was an unpaid member of the scientific board of Synaptogenix.
Annotated abstract
Correction: Clinical utility of cerebrospinal fluid biomarkers in the evaluation of cognitive impairment: a systematic review and meta-analysis
jnnp · 2026-06-12 · canonical JSON source